Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Oncolytic Virotherapy × Clear all

Phase

Phase EARLY_PHASE1 4 Phase 2/3 1 Phase 2 1 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Interventions

pembrolizumab 349 Cyclophosphamide 336 Carboplatin 272 Gemcitabine 246 Paclitaxel 243 Nivolumab 230 Cisplatin 212 Radiotherapy 191 Bevacizumab 181 Dexamethasone 167 fludarabine 163 Docetaxel 162 Rituximab 155 Capecitabine 146 Lenalidomide 134 Oxaliplatin 132 Fluorouracil 126 Temozolomide 124 Cytarabine 115 Irinotecan 113 Etoposide 109 Cetuximab 109 fludarabine phosphate 106 venetoclax 105 130-nm albumin-bound paclitaxel 97 Injections 96 Doxorubicin 96 Ipilimumab 95 Azacitidine 93 Filgrastim 91

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07145047 2025-12-19

Clinical Study of Oncolytic Virus in Glioblastoma

Mianyang Central Hospital

Phase 1/2 Recruiting

Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡